Research
-
Completed
October 2020 - December 2022
Creating a model to investigate corneal thinning in keratoconus
-
Completed
January 2020 - November 2021
Investigating genetic variants leading to AMD
Researchers are looking to determine whether this system can be used to successfully identify variant pathogenicity in AMD.
-
Active
September 2021 - August 2024
Investigation of LW/MW cone opsin disease and therapy in retinal organoids
-
Active
September 2020 - August 2025
TIGER: Surgical Trial
Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a European randomised controlled surgical trial.
-
Completed
August 2019 - July 2021
Developing hybrid antimicrobial peptides to treat corneal infection
The aim of the project is to design and develop a novel class of antimicrobial agent - human-derived hybrid AMPs - to treat corneal infection.
-
Completed
June 2019 - November 2022
Sub-retinal blood vessel damage and the development of dry AMD
The role of EPCR in choriocapillaris atrophy during age-related macular degeneration (AMD).
-
Active
May 2022 - May 2025
Pre-clinical research to treat bacteria leading to sight loss and hospitalisation
-
Active
March 2023 - March 2026
Optimising radiosensitivity of uveal melanoma by targeting DNA damage response
Researchers investigate how cancer responds to x-ray therapy proton beam therapy. This will identify drug strategies that can optimise radiotherapy treatment in promoting UM cell killing.
-
Active
August 2022 - July 2025
Investigating genetics underlying inherited corneal disease
Researchers seek to identify the underlying genetic mutations that cause inherited corneal disease.